Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketamine/Prucalopride - Silo Pharma

Next Previous
Drug Profile

Ketamine/Prucalopride - Silo Pharma

Alternative Names: SPC-14

Latest Information Update: 16 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Columbia University
  • Class Amides; Amines; Analgesics; Antidementias; Antidepressants; Antihyperglycaemics; Antiparkinsonians; Anxiolytics; Behavioural disorder therapies; Benzofurans; Chlorobenzenes; Cyclohexanes; Gastrokinetics; General anaesthetics; Irritable bowel syndrome therapies; Ketones; Laxatives; Mood stabilisers; Neuroprotectants; Neuropsychotherapeutics; Obesity therapies; Piperidines; Small molecules
  • Mechanism of Action AMPA receptor agonists; Biogenic amine uptake modulators; Dopamine receptor agonists; Nicotinic receptor modulators; NMDA receptor antagonists; Opioid receptor modulators; Serotonin 4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Alzheimer's disease

Most Recent Events

  • 06 Apr 2026 Silo Pharma receives patent allowance for SPC 15 in Europe
  • 21 Aug 2025 Pharmacodynamics data from a preclinical trail for Alzheimer's disease released by Silo Pharma
  • 28 Apr 2025 Silo Pharma has patents pending for Ketamine/Prucalopride in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top